TTK Healthcare Ltd
NSE: TTKHLTCARE BSE: 507747
₹884.40
(-0.85%)
Thu, 21 May 2026, 05:22 pm
Market Cap12.63B
PE Ratio20.81
Dividend1.12
Health Technology
Pharmaceuticals: Major
24.5KTTK Healthcare Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (2.4x coverage).
- Dividends per share have been stable in the past 10 years.
- TTK Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- TTK Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- TTK Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- TTK Healthcare is profitable, therefore cash runway is not a concern.
- TTK Healthcare is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (71.7%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 10x debt.
- TTK Healthcare's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (35% vs 11.9% today).
- TTK Healthcare earns more interest than it pays, coverage of interest payments is not a concern.
- TTK Healthcare's level of debt (11.9%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The tenure for the TTK Healthcare board of directors is about average.
- T.'s remuneration is higher than average for companies of similar size in India.
- T.'s compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
misc
- TTK Healthcare is not covered by any analysts.
- TTK Healthcare has significant price volatility in the past 3 months.
past
- TTK Healthcare's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
- TTK Healthcare's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- TTK Healthcare used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- TTK Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- TTK Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- TTK Healthcare's 1-year earnings growth is negative, it can't be compared to the IN Pharmaceuticals industry average.
value
- TTK Healthcare's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- TTK Healthcare's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- TTK Healthcare is overvalued based on assets compared to the IN Pharmaceuticals industry average.
- TTK Healthcare is overvalued based on earnings compared to the IN Pharmaceuticals industry average.
- TTK Healthcare is overvalued based on earnings compared to the India market.
- TTKHLTCARE underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- TTKHLTCARE underperformed the Market in India which returned -14.5% over the past year.
- NSEI:TTKHLTCARE is down -1.4% underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- NSEI:TTKHLTCARE is down -1.4% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Asset Management Companies
Popular Stocks
Indian Indices
Sector Wise Stocks
IPO
Share Market
Best MF Schemes
Platforms
Resources
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800